Welcome to Our Company
Call Us

Call Us

08045811974

Email

info@slogenbiotech.com
Sirolimus Tablets

Sirolimus Tablets

Product Details:

  • Salt Composition Sirolimus
  • Dosage Form Tablets
  • Indication Prevention of organ transplant rejection
  • Feature Oral administration, high bioavailability, controlled-release
  • Ingredients Sirolimus, Excipients
  • Application Immunosuppressant therapy
  • Physical Color/Texture White to off-white, film-coated tablets
  • Click to view more
X

Sirolimus Tablets Product Specifications

  • 24 months
  • Tablets
  • Prevention of organ transplant rejection
  • Sirolimus, Excipients
  • Store below 25C, protect from light and moisture
  • Oral administration, high bioavailability, controlled-release
  • Sirolimus
  • White to off-white, film-coated tablets
  • Odorless
  • Immunosuppressant therapy

Product Description

Sirolimus Tablets

We are well known exporter, distributor, supplier of Sirolimus tablets

Siropan Tablets are used for Organ transplant specially in kidney transplants for haemolytic uraemic syndrome, tuberous sclerosis complex, mantle cell lymphoma. These are prepared keeping in mind the several set parameters using modern techniques.

With the aid of experts of this industry, we introduce our clients with Biocon Sirolimus Tablets. These tablets are effective for the prophylaxis of organ rejection in patients receiving renal transplants. Biocon Sirolimus Tablets are available in various packaging options as per the demands of our clients. These tablets generally regulate the bodys immune response, so the body can accept the new organ. 

 

 



Effective Immunosuppression for Transplant Patients

Sirolimus Tablets are designed specifically for immunosuppressive therapy, primarily to prevent rejection in organ transplant recipients. With a proven mechanism as an mTOR inhibitor, sirolimus effectively reduces the body's immune response against the transplanted organ, promoting graft survival. Careful dosage regulation and ease of oral administration offer patients and healthcare professionals reliable control over immunosuppression, reducing the risk of post-transplant complications.


Manufactured to International Standards

Produced in GMP-certified facilities, Sirolimus Tablets adhere to rigorous quality and safety protocols. Each tablet is formulated with sirolimus and standardized excipients to ensure potency and stability. Markings on the tablet vary based on the strength and manufacturer, offering easy identification for users and healthcare providers alike. With a shelf life of 24 months under recommended storage, their robust packaging maintains product efficacy.


Tailored Packaging and Storage for Convenience

To suit diverse healthcare needs, Sirolimus Tablets are available in blister packs, strip packs, and bottles. Each packaging type is chosen for safety and convenience in dispensing. For optimal stability and effectiveness, the tablets should be stored below 25C and shielded from light and moisture. This ensures long-term integrity and efficacy, making them suitable for distribution, export, and supply by Indian pharmaceutical traders.

FAQ's of Sirolimus Tablets:


Q: How should Sirolimus Tablets be taken for optimal results?

A: Sirolimus Tablets should be taken orally as directed by your healthcare provider, ideally at the same time each day. Consistent timing helps maintain steady drug levels in your body, which is crucial for preventing organ rejection. Dosage adjustments may be necessary for patients with renal or hepatic impairment.

Q: What are the benefits of using Sirolimus Tablets after organ transplantation?

A: Sirolimus Tablets are highly effective in reducing the risk of organ rejection by suppressing the immune system's response to transplanted organs. This promotes long-term graft survival and minimizes the likelihood of transplant failure.

Q: When should Sirolimus Tablets not be used?

A: Sirolimus Tablets should not be taken by individuals with a known hypersensitivity to sirolimus or any of its components. Caution is advised in pregnancy (Category C), and use should only be considered if the benefits outweigh the risks.

Q: Where should Sirolimus Tablets be stored to maintain their stability?

A: Store Sirolimus Tablets below 25C in a dry, moisture-free place away from light. Proper storage helps ensure their effectiveness and stability throughout the 24-month shelf life.

Q: What common side effects should I be aware of while using Sirolimus Tablets?

A: Common side effects include an increased risk of infections, hyperlipidemia, and hypertension. Inform your physician promptly if you experience any unusual symptoms or signs of infection.

Q: What process is followed to manufacture Sirolimus Tablets?

A: Sirolimus Tablets are manufactured in GMP-certified facilities adhering to international standards. Each batch is rigorously tested for quality, potency, and safety before being packaged and distributed.

Q: Can Sirolimus Tablets be identified by their appearance?

A: Yes, Sirolimus Tablets are white to off-white, film-coated, and odorless. Tablet markings vary by manufacturer and strength, making it important to check packaging or consult your pharmacist for accurate identification.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicine' category



Back to top